BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31255669)

  • 1. Neferine and isoliensinine enhance 'intracellular uptake of cisplatin' and induce 'ROS-mediated apoptosis' in colorectal cancer cells - A comparative study.
    Manogaran P; Beeraka NM; Huang CY; Vijaya Padma V
    Food Chem Toxicol; 2019 Oct; 132():110652. PubMed ID: 31255669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of cisplatin resistance by neferine/isoliensinine and their combinatorial regimens with cisplatin-induced apoptosis in cisplatin-resistant colon cancer stem cells (CSCs).
    Manogaran P; Somasundaram B; Viswanadha VP
    J Biochem Mol Toxicol; 2022 Mar; 36(3):e22967. PubMed ID: 34921482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neferine Potentiates the Antitumor Effect of Cisplatin in Human Lung Adenocarcinoma Cells Via a Mitochondria-Mediated Apoptosis Pathway.
    Sivalingam KS; Paramasivan P; Weng CF; Viswanadha VP
    J Cell Biochem; 2017 Sep; 118(9):2865-2876. PubMed ID: 28214344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoliensinine induces apoptosis in triple-negative human breast cancer cells through ROS generation and p38 MAPK/JNK activation.
    Zhang X; Wang X; Wu T; Li B; Liu T; Wang R; Liu Q; Liu Z; Gong Y; Shao C
    Sci Rep; 2015 Jul; 5():12579. PubMed ID: 26219228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiandrogenic effect of neferine, liensinine, and isoliensinine by inhibiting 5-α-reductase and androgen receptor expression via PI3K/AKT signaling pathway in prostate cancer.
    Liu CM; Wu Z; Pan B; An L; Zhu C; Zhou J; Jiang Y
    Pharmazie; 2021 May; 76(5):225-231. PubMed ID: 33964997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neferine, an alkaloid from lotus seed embryo, inhibits human lung cancer cell growth by MAPK activation and cell cycle arrest.
    Poornima P; Weng CF; Padma VV
    Biofactors; 2014; 40(1):121-31. PubMed ID: 23983146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neferine augments therapeutic efficacy of cisplatin through ROS- mediated non-canonical autophagy in human lung adenocarcinoma (A549 cells).
    Kalai Selvi S; Vinoth A; Varadharajan T; Weng CF; Vijaya Padma V
    Food Chem Toxicol; 2017 May; 103():28-40. PubMed ID: 28223119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin induced apoptosis was potentiated by neferine in human lung adenocarcima, A549 cells.
    Poornima P; Kumar VB; Weng CF; Padma VV
    Food Chem Toxicol; 2014 Jun; 68():87-98. PubMed ID: 24632453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neferine induces reactive oxygen species mediated intrinsic pathway of apoptosis in HepG2 cells.
    Poornima P; Quency RS; Padma VV
    Food Chem; 2013 Jan; 136(2):659-67. PubMed ID: 23122111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway.
    Wang R; Ma L; Weng D; Yao J; Liu X; Jin F
    Oncol Rep; 2016 May; 35(5):3075-83. PubMed ID: 26987028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive oxygen species and mitochondrial membrane potential are modulated during CDDP-induced apoptosis in EC-109 cells.
    Jing XB; Cai XB; Hu H; Chen SZ; Chen BM; Cai JY
    Biochem Cell Biol; 2007 Apr; 85(2):265-71. PubMed ID: 17534409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The essential role of the mitochondria and reactive oxygen species in Cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma.
    Stewart JH; Tran TL; Levi N; Tsai WS; Schrump DS; Nguyen DM
    J Surg Res; 2007 Jul; 141(1):120-31. PubMed ID: 17574045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Cytoprotective and Anti-cancer Potential of Bisbenzylisoquinoline Alkaloids from
    Manogaran P; Beeraka NM; Padma VV
    Curr Top Med Chem; 2019; 19(32):2940-2957. PubMed ID: 31738137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 restoration can overcome cisplatin resistance through inhibition of Akt as well as induction of Bax.
    Kim CW; Lu JN; Go SI; Jung JH; Yi SM; Jeong JH; Hah YS; Han MS; Park JW; Lee WS; Min YJ
    Int J Oncol; 2013 Nov; 43(5):1495-502. PubMed ID: 23970333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of Liensinine, Isoliensinine, and Neferine on PC12 cells injured by amyloid-β.
    Meng XL; Liu SY; Xue JS; Gou JM; Wang D; Liu HS; Chen CL; Xu CB
    J Food Biochem; 2022 Oct; 46(10):e14303. PubMed ID: 35762411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neferine increases sensitivities to multiple anticancer drugs via downregulation of Bcl-2 expression in renal cancer cells.
    Kim EA; Jang JH; Sung EG; Song IH; Kim JY; Sohn HY; Lee TJ
    Genes Genomics; 2022 Feb; 44(2):165-173. PubMed ID: 35034280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dehydrobruceine B enhances the cisplatin-induced cytotoxicity through regulation of the mitochondrial apoptotic pathway in lung cancer A549 cells.
    Huang Z; Yang G; Shen T; Wang X; Li H; Ren D
    Biomed Pharmacother; 2017 May; 89():623-631. PubMed ID: 28262615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Phytochemical Indicaxanthin Synergistically Enhances Cisplatin-Induced Apoptosis in HeLa Cells via Oxidative Stress-Dependent p53/p21
    Allegra M; D'Anneo A; Frazzitta A; Restivo I; Livrea MA; Attanzio A; Tesoriere L
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32630700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells.
    Nakaoka T; Ota A; Ono T; Karnan S; Konishi H; Furuhashi A; Ohmura Y; Yamada Y; Hosokawa Y; Kazaoka Y
    Cell Oncol (Dordr); 2014 Apr; 37(2):119-29. PubMed ID: 24599717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
    Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
    Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.